During the pandemic, we witnessed vaccines that were being developed, seemingly satisfying all 3 of the fast, good and cheap properties.
Is this really what happened? Do they indeed possess all those 3 features?
If yes, how did that happen? How was this emergency able to circumvent the pick 2 out of 3 notion?
From what I understood, due to the circumstances the vaccine development process was able to be expedited through cooperation between the company and the FDA. The companies most likely prioritized the vaccine project above any other projects, thus funding and support was easier to acquire. In addition, the FDA made the process easier for the companies allowing multiple phases to occur at the same time and authorizing emergency use for the vaccines after they passed certain benchmarks.
I agree with @DevDesai about how the FDA allowed multiple phases to occur as multiple researchers, scientists, and governments were internationally collaborating in order to develop and distribute an effective formulation of the COVID19 vaccine. The vaccines were developed rather quickly, but the effectiveness of the vaccine preventing fatalities when contracting the disease was present and therefore approved to be rolled out. Additionally, there was a plethora of prior research regarding coronavirus vaccine research and mRNA treatments. Because the treatment was an mRNA vaccine the materials required for the vaccine were all easily produced in a controlled laboratory setting. This allowed for fast production and distribution as well when the entire world was suffering from the pandemic.
You can read more about it here:
